Dual Antiplatelet Therapy in Mild Stroke: Better at Lower BP? Dual Antiplatelet Therapy in Mild Stroke: Better at Lower BP?

A new analysis from the POINT trial suggests that a strategy of mild blood-pressure reduction combined with dual antiplatelet therapy may further lower early risk for stroke recurrence, say the authors.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news